Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin Against Cystic Fibrosis Pseudomonas aeruginosa
R. A. Murphy, M. Coates, S. Thrane, A. Sabnis, J. Harrison, S. Schelenz, A. M. Edwards, T. Vorup-Jensen, J. C. Davies
This study shows that glatiramer acetate enhances tobramycin's effectiveness against Pseudomonas aeruginosa in cystic fibrosis patients by reducing MICs and disrupting bacterial membranes.
bioRxiv · Feb 3, 2022Microbiology